Contagious caprine pleuropneumonia

Contagious caprine pleuropneumonia
Name	Contagious caprine pleuropneumonia
Synonyms	CCPP
Field	Veterinary medicine
Symptoms	Fever, respiratory distress, pleural effusion
Complications	Respiratory failure, death
Onset	Acute
Duration	Variable
Causes	Mycoplasma capricolum subspecies capripneumoniae
Diagnosis	Culture, PCR, serology, clinical signs
Differential	Pasteurellosis, caprine pneumonia complex
Treatment	Antimicrobials, supportive care
Prevention	Vaccination, biosecurity, movement control

Contagious caprine pleuropneumonia is a severe, highly contagious respiratory disease of goats caused by a specialized mycoplasma pathogen. It produces rapid outbreaks characterized by high morbidity and variable mortality that affect goat populations, veterinary services, and international trade. Control relies on diagnosis, antimicrobial treatment, vaccination programs, and coordinated animal health policies.

Taxonomy and causative agent

The etiologic agent is Mycoplasma capricolum subsp. capripneumoniae, classified within the class Mollicutes and the order Mycoplasmatales, related to other pathogenic mycoplasmas such as Mycoplasma mycoides and Mycoplasma bovis. Taxonomic placement has been refined through molecular phylogenetics including 16S rRNA sequencing and multilocus sequence analysis used by institutions like the World Organisation for Animal Health (WOAH) and laboratories affiliated with universities such as the University of Cambridge, University of Oxford, and Harvard University. Comparative genomics work by teams at Institut Pasteur, Max Planck Institute, and Chinese Academy of Sciences has clarified virulence factors, surface lipoproteins, and antigenic variation mechanisms that distinguish the pathogen from other caprine mycoplasmas. Strain diversity studies often reference reference collections maintained by Centers for Disease Control and Prevention, National Veterinary Services Laboratories, and regional veterinary research institutes in Africa and Asia.

Epidemiology and distribution

CCPP is endemic in parts of Africa, the Middle East, and Asia, with notable occurrence records from countries like Ethiopia, Kenya, Sudan, Somalia, India, Pakistan, and China. Outbreak investigation reports involve veterinary authorities such as the Food and Agriculture Organization (FAO), WOAH, African Union Inter-African Bureau for Animal Resources (AU-IBAR), and national ministries of agriculture. Transmission is primarily via close contact and respiratory droplets in herds managed under systems described in studies from the International Livestock Research Institute (ILRI) and research programs funded by Gates Foundation initiatives. Factors influencing spread include pastoral migration patterns documented in United Nations reports, live animal markets such as those in Cairo and Delhi, and cross-border trade regulated by World Trade Organization standards. Historical introductions and eradication efforts have involved cooperation with organizations like the European Commission and bilateral veterinary aid missions.

Pathogenesis and clinical signs

Pathogenesis involves colonization of the caprine respiratory tract, adhesion mediated by surface proteins, immune evasion, and induction of fibrinous pleuropneumonia. Lesions described in pathological surveys by veterinary colleges at Cornell University and the University of Sydney show lobar consolidation, pleural exudates, and bronchopneumonia. Clinical signs reported in outbreak summaries from the Royal Veterinary College and the Wellcome Trust include high fever, severe dyspnea, coughing, nasal discharge, anorexia, and weakness; acute cases may progress to death within days. Secondary complications mirror descriptions in textbooks from Oxford University Press and Cambridge University Press on livestock diseases and may be exacerbated by co-infections with Pasteurella multocida or Mannheimia haemolytica noted in veterinary microbiology literature.

Diagnosis

Definitive diagnosis combines clinical, laboratory, and serological methods. Field diagnosis relies on clinical recognition by practitioners trained at institutions like the American Veterinary Medical Association, while laboratory confirmation uses culture on specialized mycoplasma media, polymerase chain reaction (PCR) assays developed by WHO collaborating centers, and serological tests such as complement fixation and ELISA validated by WOAH reference laboratories. Advanced techniques include whole-genome sequencing at facilities like the Broad Institute and pulsed-field gel electrophoresis used in epidemiological tracing. Diagnostic differentials require exclusion of other caprine respiratory diseases recognized in manuals from FAO, Centers for Disease Control and Prevention, and textbooks by Saunders.

Treatment and control

Treatment protocols recommend specific antimicrobials effective against mycoplasmas, including macrolides (e.g., tylosin), tetracyclines, and fluoroquinolones, guided by susceptibility testing from diagnostic labs such as those at Veterinary Laboratories Agency and academic veterinary hospitals. Supportive care includes fluid therapy and anti-inflammatories. Control measures emphasize movement restrictions, quarantine enforced by national veterinary services, culling in severe outbreaks as advised by WOAH guidelines, and sanitation practices promoted by FAO and humanitarian agencies. International collaboration for outbreak response often involves emergency teams from organizations like Médicins Sans Frontières and the International Red Cross when socioeconomic impacts demand integrated interventions.

Prevention and vaccination

Preventive strategies combine vaccination, biosecurity, and surveillance. Vaccines based on inactivated whole-cell preparations are produced regionally, with development efforts reported from institutes such as the Pirbright Institute, Institut Pasteur, and Chinese Academy of Agricultural Sciences. Vaccine efficacy varies by strain match and is complemented by herd management practices recommended by ILRI and national extension services. Surveillance networks coordinated by WOAH, FAO, and national ministries monitor incidence and support contingency planning modeled on frameworks used in avian influenza and foot-and-mouth disease control programs.

Economic and public health impact

CCPP imposes significant economic losses through mortality, reduced productivity, trade restrictions, and control program costs documented in economic assessments by FAO, World Bank, and national ministries of agriculture. Social impacts affect pastoral communities studied by anthropologists at University of Cape Town and development economists at London School of Economics. Although CCPP is not considered a zoonosis, its effects on food security and livelihoods engage public health stakeholders including WHO and national public health institutes when outbreaks exacerbate poverty and malnutrition. International policy responses draw on precedents from disease control initiatives led by agencies such as the European Commission, World Bank, and bilateral development programs.

Category:Goat diseases